I get the Bioshares Daily newsletter.
On Friday, Tim Boreham wrote a piece on Oncosil.
Kenny is quoted again as saying half the Panco cohort is still alive! I listen to all opinions, and I understand the limitations of studies patient selection different treatment regimes etc etc, but if that's actually true, it's still impressive.
Also quoted as saying the launch is delayed due to cancellation of conferences due to Covid. Which might explain some fund selling.
Ann: Oncosil breakthrough device receives CE Marking approval, page-134
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.27M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.9¢ | 0.7¢ | $209.6K | 26.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 21920406 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 6056633 | 6 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| OSL (ASX) Chart |